BioWorld MedTech

July 26, 2016

Tso3's Sterizone seen as revolutionary weapon in the treatment of superbugs, other bacteria

Canada's Tso3 Inc. has won expanded FDA clearance for its Sterizone VP4 sterilizer making it the only company validated to completely sterilize large, complex and hard-to-clean medical instruments, said company CEO Ric Rumble. Read More

Co-development of companion diagnostics raises unanswered guidance questions

Zimmer's India push aims to meet growing orthopedic needs

Aiming for turnaround,Zosano presses ahead in pivotal migraine trial

Technology 'focused' on destroying prostate cancer gaining traction in U.S.

Other news to note

Product briefs

Financings

Appointments and advancements

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

BioWorld

Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...